A COMPREHENSIVE STUDY ON METABOLIC SYNDROME (NCEPATP III) AND FRAMINGHAM RISK SCORE IMPLIED CVD RISK ASSESSMENT AND MANAGEMENT OF CARDIOMETABOLIC RISK FACTORS
Zenodo (CERN European Organization for Nuclear Research)